Safety Study of Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
This study is ongoing, but not recruiting participants.
Sponsor:
Jennerex Biotherapeutics
Collaborator:
Samsung Medical Center
Information provided by (Responsible Party):
Jennerex Biotherapeutics
ClinicalTrials.gov Identifier:
NCT01380600
First received: June 22, 2011
Last updated: April 1, 2013
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2013 |
| Primary Completion Date: | November 2012 (Final data collection date for primary outcome measure) |